A common variant in BRCA2 is associated with both breast cancer risk and prenatal viability.
about
Sequencing and analysis of a South Asian-Indian personal genomeComparative analysis of cancer genes in the human and chimpanzee genomes.Kin-cohort estimates for familial breast cancer risk in relation to variants in DNA base excision repair, BRCA1 interacting and growth factor genesMore breast cancer genes?Complex genetic diseases: controversy over the Croesus code.The DNMT3B C-->T promoter polymorphism and risk of breast cancer in a British population: a case-control studyA common missense variant in BRCA2 predisposes to early onset breast cancer.Genetic epidemiology: some special contributions of birth cohortsAssessing the probability that a positive report is false: an approach for molecular epidemiology studiesRisk of contralateral breast cancer associated with common variants in BRCA1 and BRCA2: potential modifying effect of BRCA1/BRCA2 mutation carrier status.Characterization of BRCA1 and BRCA2 deleterious mutations and variants of unknown clinical significance in unilateral and bilateral breast cancer: the WECARE study.Association between common variation in 120 candidate genes and breast cancer risk.Association between the BRCA2 N372H variant and male breast cancer risk: a population-based case-control study in Tuscany, Central Italy.Association of the germline TP53 R337H mutation with breast cancer in southern Brazil.Association between the BRCA2 rs144848 polymorphism and cancer susceptibility: a meta-analysis.Two percent of men with early-onset prostate cancer harbor germline mutations in the BRCA2 geneAssociation of BRCA2 N372H polymorphism with cancer susceptibility: a comprehensive review and meta-analysis.Functional interaction between PARP-1 and PARP-2 in chromosome stability and embryonic development in mouseCandidate gene case-control studies.An MLH1 haplotype is over-represented on chromosomes carrying an HNPCC predisposing mutation in MLH1The effect of a single BRCA2 mutation on cancer in IcelandElevated dehydroepiandrosterone sulfate levels as the reproductive phenotype in the brothers of women with polycystic ovary syndrome.Pharmacogenomics and breast cancer.KIT Mutation and Loss of 14q May Be Sufficient for the Development of Clinically Symptomatic Very Low-Risk GIST.Common variants in the ATM, BRCA1, BRCA2, CHEK2 and TP53 cancer susceptibility genes are unlikely to increase breast cancer risk.Risk of non-Hodgkin lymphoma (NHL) in relation to germline variation in DNA repair and related genesBRCA2 N372H Polymorphism and Risk of Epithelial Ovarian Cancer: An Updated Meta-Analysis With 2344 Cases and 9672 Controls.Novel sequence variants and common recurrent polymorphisms of BRCA2 in Sri Lankan breast cancer patients and a family with BRCA1 mutations.Genomic Characterization of Poorly Differentiated Neuroendocrine Carcinoma in a Pediatric PatientImplication of BRCA2 -26G>A 5' untranslated region polymorphism in susceptibility to sporadic breast cancer and its modulation by p53 codon 72 Arg>Pro polymorphismPositive selection in the evolution of cancer.Mutations of the BRCA1 and BRCA2 genes in patients with bilateral breast cancer.Association of NQO1 polymorphism with spontaneous breast cancer in two independent populations.Evaluation of BRCA1 and BRCA2 mutation prevalence, risk prediction models and a multistep testing approach in French-Canadian families with high risk of breast and ovarian cancerAssociation between single-nucleotide polymorphisms in hormone metabolism and DNA repair genes and epithelial ovarian cancer: results from two Australian studies and an additional validation set.Consortium analysis of 7 candidate SNPs for ovarian cancer.Molecular epidemiology of major depressive disorder.Diverse evolutionary histories for beta-adrenoreceptor genes in humansFunctional assays for analysis of variants of uncertain significance in BRCA2.Single nucleotide polymorphisms in DNA repair genes and putative cancer risk.
P2860
Q21266697-8901EF9B-347E-4265-B8A8-BEAC23D9F7C6Q24541311-57026BC4-4977-458A-B779-B969EEE67BECQ24798716-42EECD54-173E-420D-A7AA-B0D5C6BE6EA8Q24801368-B41FDEA7-A0A5-43B5-BE51-47B599A4C096Q24805821-1C302AA3-602A-4D73-A39B-4B3608BD0701Q24806265-4BD689B9-B9AD-4FBE-B6CF-6A31BD58FFE1Q25257499-6C5E559F-FB32-4FE3-85E6-1F85DD915867Q26810034-BA430215-EF67-49A3-A493-97C46DEBFA1EQ29616285-87EC2EC8-21BB-4A41-9A77-DFC5D0E1C044Q30426599-6F5AA14B-FFBC-42D9-A78B-E333E27EBCD4Q30433040-0ED41A74-B43A-41DD-BB09-56844EAAABB2Q33279162-AC36974A-70A7-483C-B255-00C74DFAF61CQ33296526-1DC4B78F-C4C0-45C2-8EA7-94325B2E4D32Q33388533-F1BC51C0-B8DB-49AA-B1CB-C2A2EF48CF9FQ33889402-C2C333D2-AB36-48F6-90D6-097CAA10DB23Q34354479-F80DDB21-EC27-40A6-A982-8315F42A22C5Q34411413-3943E666-ED34-4557-8A19-546257C796D7Q35018839-E04416C0-4311-4CBF-8414-EAB5FD385C1BQ35073279-CC115C79-5D52-4F9B-B5CB-104DBC1AF89AQ35439545-60BB3767-2761-4793-80CB-21E00D61A620Q35440029-C731B037-4EE9-4C37-A168-17D5C0920B37Q35597056-460A1FB9-D97E-4AF6-A5CF-22A831E78F4EQ35610513-AFFC2330-3E18-40B7-8F97-0CC605520B45Q35671824-2FE1177F-B841-41FA-BD1F-C076E84DDEC7Q35794359-129F3790-57EA-4FF5-A29B-CCA2BEFE5F5BQ35849056-A6A29565-7AE8-4E5E-8C5A-6B115C5B1163Q36207059-540721BF-4539-4555-99AB-F98B3D3E97AAQ36230861-68E99224-23DE-42A3-BB9D-FE08154ED020Q36378094-1A226526-8338-4A62-ABF6-B56349A6E2D9Q36458780-0341BE69-5591-4F01-8644-EC3574842316Q36500617-3FC5E37F-A0AC-472C-B5C0-EF240C833C04Q36643361-F7514F84-9A21-49C5-B12E-9BFDA9E6A9DDQ36697159-3828F436-0892-42B1-9430-C6A6DE3DF2A1Q37004792-2AD3814A-0BD4-45D8-823C-B7B63FA8D663Q37151872-D1BD35F7-D1D6-48BB-AF66-473E061284CBQ37155532-D5CE44B0-0FBA-451B-9EC6-2C3BA496322DQ37198752-D23740C1-F1F0-4A17-9662-5910EAF2F9FAQ37253431-F116DE10-CBFB-4F61-A0B4-943CC29EAA8EQ37715826-7FA969F1-29D5-4225-B557-9CA1C4FF6701Q38873757-643DCBEB-952E-44EF-80FF-00E7733928E0
P2860
A common variant in BRCA2 is associated with both breast cancer risk and prenatal viability.
description
2000 nî lūn-bûn
@nan
2000年の論文
@ja
2000年学术文章
@wuu
2000年学术文章
@zh
2000年学术文章
@zh-cn
2000年学术文章
@zh-hans
2000年学术文章
@zh-my
2000年学术文章
@zh-sg
2000年學術文章
@yue
2000年學術文章
@zh-hant
name
A common variant in BRCA2 is a ...... r risk and prenatal viability.
@en
A common variant in BRCA2 is a ...... r risk and prenatal viability.
@nl
type
label
A common variant in BRCA2 is a ...... r risk and prenatal viability.
@en
A common variant in BRCA2 is a ...... r risk and prenatal viability.
@nl
prefLabel
A common variant in BRCA2 is a ...... r risk and prenatal viability.
@en
A common variant in BRCA2 is a ...... r risk and prenatal viability.
@nl
P2093
P50
P356
P1433
P1476
A common variant in BRCA2 is a ...... r risk and prenatal viability.
@en
P2093
P2888
P304
P356
10.1038/81691
P407
P50
P577
2000-11-01T00:00:00Z
P5875
P6179
1044693529